These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 23182923)
1. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Lu J; Huang Y; Zhao W; Marquez RT; Meng X; Li J; Gao X; Venkataramanan R; Wang Z; Li S Biomaterials; 2013 Feb; 34(5):1591-600. PubMed ID: 23182923 [TBL] [Abstract][Full Text] [Related]
2. PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel. Huang Y; Lu J; Gao X; Li J; Zhao W; Sun M; Stolz DB; Venkataramanan R; Rohan LC; Li S Bioconjug Chem; 2012 Jul; 23(7):1443-51. PubMed ID: 22681537 [TBL] [Abstract][Full Text] [Related]
3. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery. Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876 [TBL] [Abstract][Full Text] [Related]
4. PEG-derivatized birinapant as a nanomicellar carrier of paclitaxel delivery for cancer therapy. Shu X; Zhu Z; Cao D; Zheng L; Wang F; Pei H; Wen J; Yang J; Li D; Bai P; Tang M; Ye H; Peng A; Li W; Chen L Colloids Surf B Biointerfaces; 2019 Oct; 182():110356. PubMed ID: 31319226 [TBL] [Abstract][Full Text] [Related]
5. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel. Zhang X; Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Sun M; Stolz DB; Zhang L; Li S Bioconjug Chem; 2013 Mar; 24(3):464-72. PubMed ID: 23425093 [TBL] [Abstract][Full Text] [Related]
6. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751 [TBL] [Abstract][Full Text] [Related]
7. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer. Xiao K; Luo J; Fowler WL; Li Y; Lee JS; Xing L; Cheng RH; Wang L; Lam KS Biomaterials; 2009 Oct; 30(30):6006-16. PubMed ID: 19660809 [TBL] [Abstract][Full Text] [Related]
8. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer. Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661 [TBL] [Abstract][Full Text] [Related]
9. PEG-Fmoc-Ibuprofen Conjugate as a Dual Functional Nanomicellar Carrier for Paclitaxel. Zhao M; Huang Y; Chen Y; Xu J; Li S; Guo X Bioconjug Chem; 2016 Sep; 27(9):2198-205. PubMed ID: 27532881 [TBL] [Abstract][Full Text] [Related]
10. Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery. Lian H; Sun J; Yu YP; Liu YH; Cao W; Wang YJ; Sun YH; Wang SL; He ZG Int J Nanomedicine; 2011; 6():3323-34. PubMed ID: 22228999 [TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier. Zhang P; Lu J; Huang Y; Zhao W; Zhang Y; Zhang X; Li J; Venkataramanan R; Gao X; Li S AAPS J; 2014 Jan; 16(1):114-24. PubMed ID: 24281690 [TBL] [Abstract][Full Text] [Related]
13. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity. Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267 [TBL] [Abstract][Full Text] [Related]
14. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
15. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel. Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy. Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777 [TBL] [Abstract][Full Text] [Related]
17. PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel. Zhang X; Huang Y; Zhao W; Chen Y; Zhang P; Li J; Venkataramanan R; Li S Mol Pharm; 2014 Aug; 11(8):2807-14. PubMed ID: 24987803 [TBL] [Abstract][Full Text] [Related]
18. Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model. Han X; Dong X; Li J; Wang M; Luo L; Li Z; Lu X; He R; Xu R; Gong M Int J Pharm; 2017 Aug; 528(1-2):33-46. PubMed ID: 28576551 [TBL] [Abstract][Full Text] [Related]
19. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo. Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491 [TBL] [Abstract][Full Text] [Related]
20. Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel. Zhang X; Liu K; Huang Y; Xu J; Li J; Ma X; Li S Bioconjug Chem; 2014 Sep; 25(9):1689-96. PubMed ID: 25121577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]